172 related articles for article (PubMed ID: 31303421)
1. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis.
Khawar MU; Yazdani D; Zhu Z; Jandarov R; Dilling DF; Gupta N
J Heart Lung Transplant; 2019 Sep; 38(9):949-955. PubMed ID: 31303421
[TBL] [Abstract][Full Text] [Related]
2. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis.
Kpodonu J; Massad MG; Chaer RA; Caines A; Evans A; Snow NJ; Geha AS
J Heart Lung Transplant; 2005 Sep; 24(9):1247-53. PubMed ID: 16143241
[TBL] [Abstract][Full Text] [Related]
3. Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre.
Baldi BG; Samano MN; Campos SV; de Oliveira MR; Junior JEA; Carraro RM; Teixeira RHOB; Minguini IP; Burlina R; Pato EZS; Carvalho CRR; Costa AN
Lung; 2017 Dec; 195(6):699-705. PubMed ID: 28823029
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and survival following lung transplantation in patients with pulmonary Langerhans cell histiocytosis.
Wajda N; Zhu Z; Jandarov R; Dilling DF; Gupta N
Respirology; 2020 Jun; 25(6):644-650. PubMed ID: 31407478
[TBL] [Abstract][Full Text] [Related]
5. Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation-long-term follow-up of a Japanese center.
Kurosaki T; Otani S; Miyoshi K; Okazaki M; Sugimoto S; Suno M; Yamane M; Kobayashi M; Oto T; Toyooka S
Clin Respir J; 2020 Feb; 14(2):116-123. PubMed ID: 31729820
[TBL] [Abstract][Full Text] [Related]
6. [Lung transplantation in sporadic lymphangioleiomyomatosis: study of 7 cases].
Ansótegui Barrera E; Mancheño Franch N; Peñalver Cuesta JC; Vera-Sempere F; Padilla Alarcón J
Med Clin (Barc); 2013 Oct; 141(8):349-52. PubMed ID: 23937818
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis.
Salman J; Ius F; Sommer W; Siemeni T; Fleissner F; Alhadidi H; Kugler C; Avsar M; Haverich A; Warnecke G; Tudorache I; Kuhn C
Prog Transplant; 2019 Jun; 29(2):115-121. PubMed ID: 31084354
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and survival following lung transplantation in patients with Alpha-1 antitrypsin deficiency.
Riley L; Lascano J
Respir Med; 2020 Oct; 172():106145. PubMed ID: 32911139
[TBL] [Abstract][Full Text] [Related]
9. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.
Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD
Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.
Oprescu N; McCormack FX; Byrnes S; Kinder BW
Lung; 2013 Feb; 191(1):35-42. PubMed ID: 23007140
[TBL] [Abstract][Full Text] [Related]
11. Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan.
Oishi H; Watanabe T; Matsuda Y; Noda M; Ejima Y; Saiki Y; Seyama K; Kondo T; Okada Y
Surg Today; 2018 Oct; 48(10):944-950. PubMed ID: 29808303
[TBL] [Abstract][Full Text] [Related]
12. Lung transplantation for lymphangioleiomyomatosis: the European experience.
Benden C; Rea F; Behr J; Corris PA; Reynaud-Gaubert M; Stern M; Speich R; Boehler A
J Heart Lung Transplant; 2009 Jan; 28(1):1-7. PubMed ID: 19134523
[TBL] [Abstract][Full Text] [Related]
13. Lung Transplantation for Lymphangioleiomyomatosis in Japan.
Ando K; Okada Y; Akiba M; Kondo T; Kawamura T; Okumura M; Chen F; Date H; Shiraishi T; Iwasaki A; Yamasaki N; Nagayasu T; Chida M; Inoue Y; Hirai T; Seyama K; Mishima M;
PLoS One; 2016; 11(1):e0146749. PubMed ID: 26771878
[TBL] [Abstract][Full Text] [Related]
14. Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.
Maurer JR; Ryu J; Beck G; Moss J; Lee JC; Finlay G; Brown K; Chapman J; McMahan J; Olson E; Ruoss S; Sherer S;
J Heart Lung Transplant; 2007 Dec; 26(12):1293-9. PubMed ID: 18096481
[TBL] [Abstract][Full Text] [Related]
15. The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15-Year Prospective Longitudinal Analysis.
Gupta N; Lee HS; Ryu JH; Taveira-DaSilva AM; Beck GJ; Lee JC; McCarthy K; Finlay GA; Brown KK; Ruoss SJ; Avila NA; Moss J; McCormack FX;
Chest; 2019 Feb; 155(2):288-296. PubMed ID: 29940164
[TBL] [Abstract][Full Text] [Related]
16. Lung transplantation for lymphangioleiomyomatosis: the French experience.
Reynaud-Gaubert M; Mornex JF; Mal H; Treilhaud M; Dromer C; Quétant S; Leroy-Ladurie F; Guillemain R; Philit F; Dauriat G; Grenet D; Stern M
Transplantation; 2008 Aug; 86(4):515-20. PubMed ID: 18724219
[TBL] [Abstract][Full Text] [Related]
17. Lung transplantation for lymphangioleiomyomatosis.
Boehler A; Speich R; Russi EW; Weder W
N Engl J Med; 1996 Oct; 335(17):1275-80. PubMed ID: 8857007
[TBL] [Abstract][Full Text] [Related]
18. Canadian respirologists' experience with lymphangioleiomyomatosis.
Pollock-BarZiv SM; Cohen MM; Maclean H; Downey GP
Can Respir J; 2002; 9(6):413-6. PubMed ID: 12522487
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes.
Zhang J; Liu D; Yue B; Ban L; Zhou M; Wang H; Lv J; Wu B; Zhai Z; Xu KF; Chen W; Chen J
Front Med (Lausanne); 2021; 8():584826. PubMed ID: 33665195
[No Abstract] [Full Text] [Related]
20. Therapeutic Effect of Sirolimus for Lymphangioleiomyomatosis Remaining in the Abdominopelvic Region After Lung Transplantation: A Case Report.
Ito T; Suno M; Sakamoto K; Yoshizaki Y; Yamamoto K; Nakanishi R; Hirano Y; Irie M; Kurosaki T; Otani S; Yamane M; Sugimoto S; Miyoshi K; Oto T
Transplant Proc; 2016; 48(1):271-4. PubMed ID: 26915883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]